Universal Technical Institute Inc · NYSE:UTI

Universal Technical Institute — Q4 2025 Earnings Presentation

20 slides from Universal Technical Institute's earnings presentation, Nov 19, 2025

  1. Slide 1: Universal Technical Institute, Inc. Q4 2025 Financial Supplement

    Universal Technical Institute, Inc. Q4 2025 Financial Supplement

  2. Slide 2: Forward-Looking Statements

    Financial Supplement Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the safe harbor from civil liability provided for such statements by the Private Securities Litigation Reform Act of 1995 (set forth in Section 27A of the Securities Act of 193

  3. Slide 3: Consolidated Q4 and FY 2025 Highlights

    Financial Supplement Consolidated Q4 and FY 2025 Highlights Q4 2025 FY 2025 Average Full-Time Active Students Average Full-Time Active Students 25,049 24,618 Revenue Revenue $222.4 million $835.6 million Net Income Net Income $18.8 million $63.0 million Adjusted EBITDA Adjusted EBITDA $36.8 million

  4. Slide 4: Q4 2025 Summary Results

    Financial Supplement Consolidated Q4 2025 Summary Results ($ in millions) ($ in millions, except for student data) 3 Mos. 9/30/25 3 Mos. 9/30/24 YoY Change 12 Mos. 9/30/25 12 Mos. 9/30/24 YoY Change Revenues $222.4 $196.4 13.3% $835.6 $732.7 14.0% Operating expenses $197.5 $170.3 15.9% $752.1 $673.8

  5. Slide 5: Statements of Operations Trend

    Financial Supplement Consolidated Statements of Operations Trend ($ in thousands, except EPS) 12 Mos. 9/30/25 3 Mos. 9/30/25 3 Mos. 6/30/25 3 Mos. 3/31/25 3 Mos. 12/31/24 12 Mos. 9/30/24 3 Mos. 9/30/24 3 Mos. 6/30/24 3 Mos. 3/31/24 3 Mos. 12/31/23 Revenues $ 835,616 $ 222,442 $ 204,298 $ 207,447 $ 2

  6. Slide 6: Results of Operations Trend Percent of Revenue

    Financial Supplement Consolidated Results of Operations Trend Percent of Revenue 12 Mos. 3 Mos. 3 Mos. 3 Mos. 3 Mos. 12 Mos. 3 Mos. 3 Mos. 3 Mos. 3 Mos. 9/30/25 9/30/25 6/30/25 3/31/25 12/31/24 9/30/24 9/30/24 6/30/24 3/31/24 12/31/23 Revenues 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%

  7. Slide 7: Quarterly Trend – Segment Key Metrics

    Financial Supplement Quarterly Trend – Segment Key Metrics ($ in millions, except revenue per student amounts) ($ in millions, except for student data) 3 Mos. 3 Mos. 3 Mos. 3 Mos. 3 Mos. 3 Mos. 3 Mos. 3 Mos. 3 Mos. 3 Mos. 9/30/25 6/30/25 3/31/25 12/31/24 9/30/24 9/30/25 6/30/25 3/31/25 12/31/24 9/30

  8. Slide 8: Segment Results of Operations - Fourth Quarter

    Financial Supplement Segment Results of Operations - Fourth Quarter ($ in thousands) PAGE 8 3 Mos. 3 Mos. 3 Mos. 3 Mos. 3 Mos. 3 Mos. 3 Mos. 3 Mos. 9/30/25 9/30/25 9/30/25 9/30/25 9/30/24 9/30/24 9/30/24 9/30/24 UTI Concorde Corporate Consolidated UTI Concorde Corporate Consolidated Revenues $ 144,6

  9. Slide 9: Segment Results of Operations - YTD

    Financial Supplement Segment Results of Operations - YTD ($ in thousands) PAGE 9 12 Mos. 12 Mos. 12 Mos. 12 Mos. 12 Mos. 12 Mos. 12 Mos. 12 Mos. 9/30/25 9/30/25 9/30/25 9/30/25 9/30/24 9/30/24 9/30/24 9/30/24 UTI Concorde Corporate Consolidated UTI Concorde Corporate Consolidated Revenues $ 541,816

  10. Slide 10: Consolidated Balance Sheet and Cash Flow Summary

    Financial Supplement Note: On December 18, 2023, the Company exercised in full its right of conversion of the Company’s Series A Preferred Stock which resulted in the conversion of all outstanding Series A Preferred shares into19,296,843 shares of Common Stock. Consolidated Balance Sheet and Cash Fl

  11. Slide 11: Earnings Per Share Trend and Guidance

    Financial Supplement Earnings Per Share Trend and Guidance ($ in thousands, except EPS) Fiscal 2026 Midpoints 12 Mos. 9/30/25 3 Mos. 9/30/25 3 Mos. 6/30/25 3 Mos. 3/31/25 3 Mos. 12/31/24 12 Mos. 9/30/24 3 Mos. 9/30/24 3 Mos. 6/30/24 3 Mos. 3/31/24 3 Mos. 12/31/23 Net Income ~$40,000-45,000 $ 63,018

  12. Slide 12: Leverage as of 9/30/2025

    Financial Supplement Leverage as of 9/30/2025 Current Loan Balances, net $87.1M LTM EBITDA $126.5M Cash, Cash Equivalents, and Short-Term Investments $169.1M Gross Leverage Ratio 0.69x Net Leverage Ratio (0.65x) Debt as of 9/30/2025 Term Loan: Avondale Campus Original Note Amount $31.2M Inception Da

  13. Slide 13: Use of Non-GAAP Financial Information

    Financial SupplementUse of Non-GAAP Financial Information PAGE 13 In addition to disclosing financial results that are determined in accordance with U.S. generally accepted accounting principles ("GAAP"), the Company also discloses certain non-GAAP financial information. These financial measures are

  14. Slide 14: Adjusted EBITDA Reconciliation Trend

    Financial Supplement Consolidated Adjusted EBITDA Reconciliation Trend ($ in thousands) 1. Costs related to both announced and potential acquisition targets. 2. In fiscal 2025, the Company received $0.7 million in funds in final settlement of the outstanding escrow accounts affiliated with the purch

  15. Slide 15: Adjusted EBITDA Reconciliation Trend

    Financial Supplement Consolidated Adjusted EBITDA Reconciliation Trend ($ in thousands) 12 Mos. 9/30/25 9 Mos. 6/30/25 6 Mos. 3/31/25 3 Mos. 12/31/24 12 Mos. 9/30/24 9 Mos. 6/30/24 6 Mos. 3/31/24 3 Mos. 12/31/23 Net income, as reported $ 63,018 $ 44,262 $ 33,599 $ 22,153 $ 42,001 $ 23,161 $ 18,176 $

  16. Slide 16: Adjusted EBITDA Reconciliation By Segment

    Financial Supplement Adjusted EBITDA Reconciliation By Segment ($ in thousands) 3 Mos. 9/30/25 3 Mos. 9/30/24 3 Mos. 9/30/25 3 Mos. 9/30/24 3 Mos. 9/30/25 3 Mos. 9/30/24 UTI UTI Concorde Concorde Corporate Corporate Net income (loss), as reported $ 26,807 $ 28,760 $ 10,109 $ 6,777 $ (18,160) $ (16,6

  17. Slide 17: Adjusted EBITDA Reconciliation By Segment

    Financial Supplement Adjusted EBITDA Reconciliation By Segment ($ in thousands) 12 Mos. 9/30/25 12 Mos. 9/30/24 12 Mos. 9/30/25 12 Mos. 9/30/24 12 Mos. 9/30/25 12 Mos. 9/30/24 UTI UTI Concorde Concorde Corporate Corporate Net income (loss), as reported $ 89,901 $ 71,646 $ 36,001 $ 21,048 $ (62,884)

  18. Slide 18: Adjusted EBITDA Reconciliation Trend By Segment

    Financial Supplement Adjusted EBITDA Reconciliation Trend By Segment ($ in thousands) 3 Mos. 9/30/25 3 Mos. 6/30/25 3 Mos. 3/31/25 3 Mos. 12/31/24 3 Mos. 9/30/24 3 Mos. 9/30/25 3 Mos. 6/30/25 3 Mos. 3/31/25 3 Mos. 12/31/24 3 Mos. 9/30/24 UTI UTI UTI UTI UTI Concorde Concorde Concorde Concorde Concor

  19. Slide 19: Adjusted Free Cash Flow

    Financial Supplement Consolidated Adjusted Free Cash Flow ($ in thousands) 3 Mos. 9/30/25 3 Mos. 9/30/24 12 Mos. 9/30/25 12 Mos. 9/30/24 Cash flow provided by operating activities, as reported $57,104 $67,534 $97,330 $85,895 Purchase of property and equipment (16,479) (7,529) (41,978) (24,298) Free

  20. Slide 20: Slide 20

Universal Technical Institute — Q4 2025 Earnings Presentation on 6ix